On the presumed inaccuracy of the Friedewald formula in hypertriglyceridemic plasma: A role for imprecise analysis?

Clinical Chemistry

Volumn 42, Issue 9, 1996, Pages 1491-1494

  Demacker, Pierre N M ^a   Toenhake Dijkstra, Helga ^a   De Rijke, Yolanda B ^a   Stalenhoef, Anton F H ^a   Stuyt, Paul M J ^a   Willems, Hans L ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ACCURACY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; HUMAN; HYPERLIPOPROTEINEMIA; HYPERTRIGLYCERIDEMIA; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0029738409     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/42.9.1491     Document Type: Article

References (24)

1. Report of the National Cholesterol Education Program Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults. Arch Intern Med 1988;149:36-69.
2. McNamara JR, Cohn JS, Wilson PWF, Schaefer EJ. Calculated values for low density lipoprotein cholesterol in the assessment of lipid abnormalities and coronary disease risk. Clin Chem 1990;36:36-42.
3. Rifai N, Warnick GR, McNamara JR, Belcher JD, Grinstead GF, Franz ID Jr. Measurement of low-density-lipoprotein cholesterol in serum: a status report. Clin Chem 1992;38:150-60.
4. Marniemi J, Mäki J, Maatela J, Järvisalo J, Impivaara O. Poor applicability of the Friedewald formula in the assessment of serum LDL cholesterol for clinical samples. Clin Biochem 1995;28:285-9.
5. Jialal I, Hirany SV, Devaraj S, Sherwood TA. Companion of an immunoprecipitation method for direct measurement of LDL-chol with beta-quantitation (ultracentrifugation). Am J Clin Pathol 1995;104:76-81.
6. Matas C, Cabre M, La Ville A, Prats E, Joven J, Turner PR, et al. Limitations of the Friedewald formula for estimating low-density lipoprotein cholesterol in alcoholics with liver disease. Clin Chem 1994;40:404-6.
7. Branchi A, Rovellini A, Fiorenza AM, Torri A, Prandi W, Tomella C, et al. Estimation of cardiovascular risk: total cholesterol versus lipoprotein profile. Int J Clin Lab Res 1994;24:106-12.
8. Demacker PNM, Hijmans AGM, Brenninkmeijer BJ, Jansen AP, van 't Laar A. Five methods for determining low density lipoprotein cholesterol compared. Clin Chem 1984;30:1797-800.
9. McNamara JR, Cole TG, Contols JH, Ferguson CA, Ordovas JM, Schaefer EJ. Immunoseparation method for measuring low-density lipoprotein cholesterol directly from serum evaluated. Clin Chem 1995;41:232-40.
10. Fredrickson DS, Levy RI, Lees RS. Fat transport in lipoproteins. N Engl J Med 1967;276:34-44, 94-103, 148-56, 215-26, 273-81.
11. Morganroth J, Levy RI, Fredrickson DS. The biochemical, clinical and genetic features of type III hyperlipoproteinemia. Ann Int Med 1975;82:158-74.
12. Weidman SW, Suarez B, Falko JM, Witztum JL, Kolar J, Raben M, Schonfeld G. Type III hyperlipoproteinemia: development of a VLDL apo E isoelectric focusing technique and application in family studies. J Lab Clin Med 1979;93:549-69.
13. Demacker PNM, Vos-Janssen HE, Jansen AP, van 't Laar A. Evaluation of the dual precipitation method by comparison with the ultracentrifugation method for measurement of lipoproteins in serum. Clin Chem 1977;23: 1238-44.
14. Wilson PW, Abbott RD, Garrison RJ, Castelli WP. Estimation of very-low-density lipoprotein cholesterol from data on triglyceride concentration in plasma. Clin Chem 1981;27:2008-10.
15. Demacker PNM, van Oppenraay JBHA, Baadenhuijsen H, Jansen AP. An improved semi-automated method for the colorimetric determination of triglycerides in serum. Clin Chim Acta 1975;64:45-50.
16. Demacker PNM, Hijmans AGM, Vos-Janssen HE, van 't Laar A, Jansen AP. A study of the use of polyethylene glycol in estimating cholesterol in high density lipoprotein. Clin Chem 1980;26:1775-9.
17. Demacker PNM, Vos-Janssen HE, Hijmans AGM, van 't Laar A, Jansen AP. Measurement of high-density lipoprotein cholesterol in serum: comparison of six isolation methods combined with enzymatic cholesterol analysis. Clin Chem 1980;26:1780-6.
18. Passing H, Bablock W. A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry. Part 1. J Clin Chem Clin Biochem 1983;21:709-20.
19. Demacker PNM. Accuracy and precipitation efficiency of improved precipita-tion methods for quantifying high-density lipoprotein cholesterol. Clin Chem 1985;31:1768-70.
20. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
21. Swinkels DW, Demacker PNM, Hendricks JCM, van 't Laar A. Low density lipoprotein subfractions and the relationship to other risk factors for coronary artery disease in healthy volunteers. Arteriosclerosis 1989;9:604-13.
22. Swinkels DW, Demacker PNM, Hendriks JCM, Brenninkmeijer BJ, Stuyt PMJ. The relevance of a protein-enriched low density lipoprotein as a risk factor for coronary heart disease in relation to other known risk factors. Atherosclerosis 1989;77:59-67.
23. Sniderman A, Shapiro S, Marpole D, Skinner B, Teng B, Kwiterovitch PO. Association of coronary atherosclerosis with hyperapobetalipoproteinemia (increased protein but normal cholesterol levels in human plasma low density (β) lipoproteins. Proc Natl Acad Sci USA, 1980;77:604-8.
24. Campos H, Genest JJ, Blijlevens E. Low density lipoprotein particle size and coronary atherosclerotic disease. Arterioscler Thromb 1992;12:187-95.